PubRank

Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: a randomized controlled trial.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 26201639)

Published in Hepatol Int on March 10, 2012

Authors

Shiv Kumar Sarin1,2,3, Smruti Ranjan Mishra4, Praveen Sharma5, Barjesh Chander Sharma4, Ashish Kumar5,6

Author Affiliations

1: Department of Hepatology, Institute of Liver and Biliary Sciences (ILBS), D-1, Vasant Kunj, New Delhi, 110070, India. shivsarin@gmail.com.
2: Department of Gastroenterology, GB Pant Hospital, University of Delhi, New Delhi, India. shivsarin@gmail.com.
3: Special Centre for Molecular Medicine (SCMM), Jawaharlal Nehru University (JNU), New Delhi, India. shivsarin@gmail.com.
4: Department of Gastroenterology, GB Pant Hospital, University of Delhi, New Delhi, India.
5: Department of Hepatology, Institute of Liver and Biliary Sciences (ILBS), D-1, Vasant Kunj, New Delhi, 110070, India.
6: Special Centre for Molecular Medicine (SCMM), Jawaharlal Nehru University (JNU), New Delhi, India.

Articles citing this ↘

UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut (2015) 1.20

Nonselective beta-blockers in cirrhotic patients with no or small varices: A meta-analysis. World J Gastroenterol (2015) 0.83

Recent advances in the management of variceal bleeding. Gastroenterol Rep (Oxf) (2017) 0.76

Is the use of non-selective beta-blockers necessary in cirrhotic patients with small varices? Ann Gastroenterol (2014) 0.75